Veritas Pharma Enters into agreement to acquire Commercial Hemp and Cannabis Processing Facility

VANCOUVER, British Columbia, Feb. 12, 2019 (GLOBE NEWSWIRE) — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it has entered into an agreement with TG Initiatives Ltd., to purchase a commercial processing facility for hemp and cannabis products(“asset”), that asset is capable of making a variety of hemp and cannabis products including edibles for human and animal use. Additionally, this asset provides the capability to make a variety of natural topical creams for pain relief and other ailments including any product that come out of the company’s acute pain reduction human trials recently announced in Puerto Rico. 

Veritas’ director, Nick Standish, commented, “this is an exciting development for Veritas as it further develops our ability to commercialize our proprietary hemp and cannabis products, in addition to expanding our production potential to topical creams and edibles

... read more at: https://globenewswire.com/news-release/2019/02/12/1720860/0/en/Veritas-Pharma-Enters-into-agreement-to-acquire-Commercial-Hemp-and-Cannabis-Processing-Facility.html

by